Brookfield Asset Management Inc. Pacific Biosciences Of California, Inc. Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	BUY	$9.97 - $14.05 $151,334 - $213,264	15,179 Added 5.67%	282,763 $3.76 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $151,334 - $213,264	15,179 Added 5.67%	282,763 $3.76 Million
Q1 2023 Sep 25, 2023	SELL	$7.94 - $12.02 $120,521 - $182,451	-15,179 Reduced 5.37%	267,584 $3.1 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $2.12 Million - $3.22 Million	267,584 New	267,584 $3.1 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.